Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd
Orca
Pharma

Orca Bio takes commercial leap with FDA approval for Tregzi

Orca Bio is charging the WAC of $428,000 for Tregzi, a novel regulatory T cell-based therapy for blood cancer patients requiring transplants.
Angus Liu Jul 1, 2026 12:14am
reputation rating ranking

Roche tops cancer reputation rankings as AstraZeneca climbs back

Jul 2, 2026 6:00am
Tenpoint blurry vision DTC campaign

Tenpoint brings blurry vision hassles to life in new campaign

Jul 1, 2026 4:37pm
Lonza headquarters

Lonza to expand ADC capacity, broaden collab with US drugmaker

Jul 1, 2026 3:22pm
Sanofi

Sanofi unit in Ireland dinged by FDA on Altuviiio production

Jul 1, 2026 2:52pm
Magnifying glass with pills on blue

Regulatory tracker: Sarepta's DMD drugs get FDA decision date

Jul 1, 2026 2:10pm
More News

Sixth Street, KKR invest up to $1B to propel BridgeBio launches

Jul 1, 2026 11:35am

Kimball makes $103M bid to grow its CDMO footprint in EU, India

Jul 1, 2026 10:22am

Haleon joins the AI deal wave with Microsoft collab

Jul 1, 2026 10:14am

AstraZeneca settles Texas kickback lawsuit, agreeing to pay $34M

Jun 30, 2026 2:46pm